{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:36:32Z","timestamp":1793108192443,"version":"4.5.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,19]]},"abstract":"<jats:p>Ankylosing spondylitis (AS) and multiple sclerosis (MS) are chronic immune-mediated disorders with overlapping epidemiological and genetic features, but their causal relationship remains unclear. In this study, we performed a 2-sample Mendelian randomization (MR) analysis using large-scale genome-wide association study summary statistics from European populations to investigate whether AS causally influences the risk of MS. Instrumental variables were selected based on stringent significance, independence, and validity criteria. The primary MR analyses, including the inverse variance weighted method, indicated that AS is associated with an increased risk of MS (odds ratio\u2005=\u20052.18, 95% confidence interval: 1.31\u20133.63, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.00), and this finding was supported by the MR Egger method. Sensitivity analyses confirmed the robustness of the results. Inverse MR analysis found no evidence for a causal effect of MS on AS. These findings contribute to the understanding of the shared genetic architecture and pathophysiological pathways between AS and MS. Further studies in more diverse populations and with nonlinear models are warranted to validate and extend these findings.<\/jats:p>","DOI":"10.1097\/md.0000000000044788","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:01:07Z","timestamp":1758571267000},"page":"e44788","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Causal relationship between ankylosing spondylitis and multiple sclerosis: Evidence from 2-sample Mendelian randomization"],"prefix":"10.1097","volume":"104","author":[{"given":"Rui","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Xiangya Hospital of Central South University, Changsha, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Peng","sequence":"additional","affiliation":[{"name":"School of Mathematics and Statistics, Central South University, Changsha, Hunan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9328-0694","authenticated-orcid":false,"given":"Yongbing","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Xiangya Hospital of Central South University, Changsha, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250928","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review.","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"key":"R2-20250928","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.","volume":"26","author":"Walton","year":"2020","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)"},{"key":"R3-20250928","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2023.03.008","article-title":"Multiple sclerosis: neuroimmune crosstalk and therapeutic targeting.","volume":"186","author":"Charabati","year":"2023","journal-title":"Cell"},{"key":"R4-20250928","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis.","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"R5-20250928","doi-asserted-by":"crossref","first-page":"ITC81","DOI":"10.7326\/AITC202106150","article-title":"Multiple sclerosis.","volume":"174","author":"Olek","year":"2021","journal-title":"Ann Intern Med"},{"key":"R6-20250928","doi-asserted-by":"crossref","first-page":"113709","DOI":"10.1016\/j.intimp.2024.113709","article-title":"Ankylosing spondylitis: From pathogenesis to therapy.","volume":"145","author":"Wei","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"R7-20250928","doi-asserted-by":"crossref","first-page":"e37297","DOI":"10.1097\/MD.0000000000037297","article-title":"Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment.","volume":"103","author":"Haki","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"R8-20250928","doi-asserted-by":"crossref","first-page":"s53","DOI":"10.7861\/clinmedicine.16-6-s53","article-title":"Multiple sclerosis, a treatable disease.","volume":"16","author":"Doshi","year":"2016","journal-title":"Clin Med"},{"key":"R9-20250928","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis. Longo DL, ed.","volume":"374","author":"Taurog","year":"2016","journal-title":"N Engl J Med"},{"key":"R10-20250928","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","article-title":"Ankylosing spondylitis: an autoimmune or autoinflammatory disease?","volume":"17","author":"Mauro","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"R11-20250928","doi-asserted-by":"crossref","first-page":"996103","DOI":"10.3389\/fimmu.2022.996103","article-title":"Joint together: the etiology and pathogenesis of ankylosing spondylitis.","volume":"13","author":"Xiong","year":"2022","journal-title":"Front Immunol"},{"key":"R12-20250928","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis.","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology (Oxford, England)"},{"key":"R13-20250928","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.12688\/f1000research.14956.1","article-title":"Recent advances in ankylosing spondylitis: understanding the disease and management.","volume":"7","author":"Garcia-Montoya","year":"2018","journal-title":"F1000Research"},{"key":"R14-20250928","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3892\/mmr.2017.6248","article-title":"Role of HLA-B27 in the pathogenesis of ankylosing spondylitis (Review).","volume":"15","author":"Chen","year":"2017","journal-title":"Mol Med Rep"},{"key":"R15-20250928","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s10067-021-05679-7","article-title":"Ankylosing spondylitis risk factors: a systematic literature review.","volume":"40","author":"Hwang","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R16-20250928","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1080\/09638288.2022.2140842","article-title":"Impact of different types of exercise programs on ankylosing spondylitis: a systematic review and meta-analysis.","volume":"45","author":"Boudjani","year":"2023","journal-title":"Disabil Rehabil"},{"key":"R17-20250928","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.apmr.2017.07.015","article-title":"Effectiveness of exercise programs in ankylosing spondylitis: a meta-analysis of randomized controlled trials.","volume":"99","author":"P\u00e9courneau","year":"2018","journal-title":"Arch Phys Med Rehabil"},{"key":"R18-20250928","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2217\/imt-2019-0094","article-title":"Ixekizumab for treating ankylosing spondylitis.","volume":"11","author":"Kiwalkar","year":"2019","journal-title":"Immunotherapy"},{"key":"R19-20250928","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jocn.2017.06.031","article-title":"Coexistence of multiple sclerosis and ankylosing spondylitis: report of four cases from Russia and review of the literature.","volume":"44","author":"Fominykh","year":"2017","journal-title":"J Clin Neurosci"},{"key":"R20-20250928","doi-asserted-by":"crossref","first-page":"102889","DOI":"10.1016\/j.msard.2021.102889","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disorders coexisting with ankylosing spondylitis: potential association between demyelination and tumor necrosis factor inhibitors.","volume":"51","author":"Luo","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"R21-20250928","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.tig.2017.09.004","article-title":"The genetics of multiple sclerosis: from 0 to 200 in 50 Years.","volume":"33","author":"Baranzini","year":"2017","journal-title":"Trends Genet"},{"key":"R22-20250928","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/ard.48.12.971","article-title":"Is there an association between ankylosing spondylitis and multiple sclerosis?","volume":"48","author":"Calin","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"R23-20250928","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2217\/imt-2021-0128","article-title":"Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature review.","volume":"14","author":"Eksin","year":"2022","journal-title":"Immunotherapy"},{"key":"R24-20250928","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"R25-20250928","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.","volume":"45","year":"2013","journal-title":"Nat Genet"},{"key":"R26-20250928","doi-asserted-by":"crossref","first-page":"e1501678","DOI":"10.1126\/sciadv.1501678","article-title":"Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.","volume":"2","author":"Andlauer","year":"2016","journal-title":"Sci Adv"},{"key":"R27-20250928","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"key":"R28-20250928","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R29-20250928","doi-asserted-by":"crossref","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.","volume":"365","author":"Patsopoulos","year":"2019","journal-title":"Science"},{"key":"R30-20250928","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cyto.2017.10.024","article-title":"Multiple sclerosis genetics: results from meta-analyses of candidate-gene association studies.","volume":"106","author":"Tizaoui","year":"2018","journal-title":"Cytokine"},{"key":"R31-20250928","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system.","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J Clin Invest"},{"key":"R32-20250928","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R33-20250928","first-page":"k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Nm","year":"2018","journal-title":"BMJ"},{"key":"R34-20250928","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/aje\/kwu283","article-title":"Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.","volume":"181","author":"Burgess","year":"2015","journal-title":"Am J Epidemiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044788","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:01:52Z","timestamp":1759046512000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":34,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044788","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"2025-06-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}